Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. (Q44355905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Jules Dienstag

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Eugene Schiff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Nancy W Y Leung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Mark Atkins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Christine Hunt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Nathaniel Brown

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Mary Woessner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Richard Boehme

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Lynn Condreay

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

5 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

687-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

Long-term mutation rates in the hepatitis B virus genome

1 November 2019

cites work

1 reference

Antiviral resistance: mechanisms, clinical significance, and future implications

21 January 2018

1 reference

A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group

21 January 2018

1 reference

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

21 January 2018

1 reference

A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.

21 January 2018

1 reference

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

21 January 2018

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies

21 January 2018

1 reference

Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation

21 January 2018

1 reference

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

21 January 2018

1 reference

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

Functional analysis of mutations conferring lamivudine resistance on hepatitis B virus

21 January 2018

1 reference

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

21 January 2018

1 reference

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

21 January 2018

1 reference

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

21 January 2018

1 reference

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

21 January 2018

1 reference

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

21 January 2018

1 reference

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy

21 January 2018

1 reference

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

21 January 2018

1 reference

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

21 January 2018

1 reference

Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation

21 January 2018

1 reference

Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.

21 January 2018

1 reference

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

21 January 2018

1 reference

Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B.

21 January 2018

1 reference

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

21 January 2018

1 reference

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

21 January 2018

1 reference

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

21 January 2018

1 reference

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation

21 January 2018

1 reference

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

21 January 2018

1 reference

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/368083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12627352%20AND%20SRC:MED&resulttype=core&format=json

release_5uscj757ynbbnj776dpcgolvw4

1 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5uscj757ynbbnj776dpcgolvw4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference